Mizuki Nishino
机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center · ORCID：0000-0003-0275-0502
发表论文 828 篇 · 总被引 25326 次 · h-index 82
代表论文
- MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies (2026 · Annals of Oncology · 被引 8)
- Automated interstitial lung abnormalities detection at CT: external validation and potential recognition of traction bronchiectasis/bronchiolectasis (2025 · Japanese Journal of Radiology · 被引 1)
- Supplementary Data1 from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)
- Data from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)
- How I Do It: Understanding and Leveraging Generative AI for Chest Radiology Reporting (2026 · Radiology)
- Tumor Mutational Burden as a Predictor of Immune-Related Adverse Events in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Brief Report (2026 · Journal of Thoracic Oncology)